Table of Contents
PharmSights
| Cyclosporin A Enhances Cell Survival in Neural Precursor Populations in the Adult Central Nervous System |
Abstract PDF |
| Jessica Hunt, Cindi Morshead |
81-88 |
| DP2 Receptor Antagonists: Novel Therapeutic Target for COPD |
Abstract PDF |
| Karin J. Stebbins, Jilly F. Evans, Daniel S. Lorrain |
89-96 |
| Implications of a Newly Discovered DR5 Specific Antagonistic Peptide for Neurodegenerative Disorders |
Abstract PDF |
| Mariette S. Heins, Wim J. Quax |
97-100 |
Research Articles
| Mitochondrial and Plasma Membrane Citrate Transporters: Discovery of Selective Inhibitors and Application to Structure/Function Analysis |
Abstract PDF |
| Jiakang Sun, Sreevidya Aluvila, Rusudan Kotaria, June A. Mayor, D. Eric Walters, Ronald S. Kaplan |
101-110 |
Reviews
| G Protein-Coupled Receptor 87: a Promising Opportunity for Cancer Drug Discovery |
Abstract PDF |
| Yanhong Zhang, Ariane Scoumanne, Xinbin Chen |
111-116 |
| The “Two faces” of Tumor Suppressor p53-revisited |
Abstract PDF |
| Martin L. Smith, M.A. Suresh Kumar |
117-119 |
FDA Corner
| FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women |
Abstract PDF |
| |
121 |
| FDA Approves New Treatment for Late-Onset Pompe Disease |
Abstract PDF |
| |
121-122 |
| FDA Approves New Combination Product Oral Contraceptive |
Abstract PDF |
| |
122 |
| FDA Approves a Cellular Immunotherapy for Men with Advanced Prostate Cancer |
Abstract PDF |
| |
122-123 |
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.
